본문으로 건너뛰기
← 뒤로

Severe exfoliative dermatitis induced by apalutamide in a mHSPC patient: A case report.

Medicine 2026 Vol.105(7) p. e47428

Chen H, Li T, Fan J, Liu J

📝 환자 설명용 한 줄

[RATIONALE] Apalutamide is a generation androgen antagonist for the treatment of metastatic hormone sensitive prostate cancer and non-metastatic castration resistant prostate cancer.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Chen H, Li T, et al. (2026). Severe exfoliative dermatitis induced by apalutamide in a mHSPC patient: A case report.. Medicine, 105(7), e47428. https://doi.org/10.1097/MD.0000000000047428
MLA Chen H, et al.. "Severe exfoliative dermatitis induced by apalutamide in a mHSPC patient: A case report.." Medicine, vol. 105, no. 7, 2026, pp. e47428.
PMID 41686612

Abstract

[RATIONALE] Apalutamide is a generation androgen antagonist for the treatment of metastatic hormone sensitive prostate cancer and non-metastatic castration resistant prostate cancer. Skin adverse reactions caused by apalutamide are mostly rashes and maculopapules.

[PATIENT CONCERNS] There are a few reports about exfoliative dermatitis caused by apalutamide.

[DIAGNOSES] Severe exfoliative dermatitis induced by apalutamide.

[INTERVENTIONS] Gamma globulin, cefoperazone sulbactam sodium, albumin, ebastine, loratadine, hydrocortisone cream, and 3% boric acid lotion.

[OUTCOMES] Whole-body skin was red, without exudation, and with a small amount of desquamation.

[LESSONS] The incidence of exfoliative dermatitis due to apalutamide is low but severe, and if a serious adverse skin reaction is suspected, apalutamide needs to be discontinued immediately and treated accordingly.

MeSH Terms

Humans; Male; Thiohydantoins; Dermatitis, Exfoliative; Prostatic Neoplasms, Castration-Resistant; Aged

같은 제1저자의 인용 많은 논문 (5)